Turn Therapeutics Inc. Common Stock Share Price
NASDAQ: TTRX
Live Turn Therapeutics Inc. Common Stock Share Price Chart
O H L
Turn Therapeutics Inc. Common Stock Performance Overview
Days Range
▼
$13.99Low
$14.25High
Markets Today
| Previous Close | $13.82 |
|---|---|
| Open | $14.25 |
| Volume | 29,515 |
| Day's Range | $13.99 - $14.25 |
| 52W Range | NA |
| Market Cap | $416.64 M |
Historical Performance
| 1M Returns | +38.34 |
|---|---|
| 3M Returns | +135.43 |
| 6M Returns | +297.13 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
Turn Therapeutics Inc. Common Stock Fundamentals
| Market Cap | $416.64 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-5.81 M |
| Profit Margin | N/A |
| Market Cap | $416.64 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-5.81 M |
| Profit Margin | N/A |
Turn Therapeutics Inc. Common Stock Profit & Loss
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 |
| Operating Income | -$2.19 M | -$1.25 M | -$1.63 M |
| EBITDA | -$2.18 M | -$1.23 M | -$1.64 M |
| Interest Expense | $0 | $0 | -$241.36 K |
| Depreciation | $14.15 K | $14.45 K | -$14.45 K |
| Income Before Tax | $279.07 K | -$970.97 K | -$5.85 M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income + | $279.07 K | -$970.97 K | -$5.85 M |
| Net Profit Margin | - | - | - |
Turn Therapeutics Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Share Capital | $2.94 K | $2.98 K | $2.98 K |
| Reserve & Surplus | -$22.39 M | -$23.36 M | -$29.21 M |
| Non-Current Liabilities | $1.47 M | $7.40 M | $7.51 M |
| Current Liabilities | $6.00 M | $5.13 M | $8.76 M |
| Total Liabilities | $7.48 M | $12.53 M | $16.27 M |
| Fixed Assets | $922.17 K | $919.95 K | $911.22 K |
| Current Assets | $5.20 M | $11.45 M | $10.43 M |
| Total Assets | $12.16 M | $18.64 M | $16.96 M |
Turn Therapeutics Inc. Common Stock Cash Flow
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Net Income | $279.07 K | -$970.97 K | -$5.85 M |
| Operating Cash Flow | -$1.18 M | -$1.63 M | -$923.36 K |
| Investing Cash Flow | -$31.44 K | -$12.23 K | -$5.80 K |
| Financing Cash Flow | $3.18 M | $7.79 M | $1 |
| Change in Cash | $1.97 M | $6.14 M | -$929.16 K |
Turn Therapeutics Inc. Common Stock Return Calculator
The Turn Therapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Turn Therapeutics Inc. Common Stock
Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.
Popular Stocks
FAQs
What is the share price of Turn Therapeutics Inc. Common Stock today?
Turn Therapeutics Inc. Common Stock (TTRX) share price as of September 18, 2026 is $14.09. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Turn Therapeutics Inc. Common Stock?
Yes, Indian Investors can invest in the Turn Therapeutics Inc. Common Stock (TTRX) Share by opening an international trading account with Angel One.
How can I purchase Turn Therapeutics Inc. Common Stock shares in India?
Purchasing Turn Therapeutics Inc. Common Stock (TTRX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Turn Therapeutics Inc. Common Stock (TTRX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Turn Therapeutics Inc. Common Stock?
Yes, you can purchase fractional shares of Turn Therapeutics Inc. Common Stock (TTRX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Turn Therapeutics Inc. Common Stock?
The market capitalization of Turn Therapeutics Inc. Common Stock on September 18, 2026, is $416.64 M.
In which sector Turn Therapeutics Inc. Common Stock belongs?
Turn Therapeutics Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in Turn Therapeutics Inc. Common Stock stocks?
In order to invest in Turn Therapeutics Inc. Common Stock (TTRX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
